Education, AI and More at ASH 2024
November 25, 2024 |
Medscape will showcase eight educational symposia and three posters at ASH 2024, highlighting advancements in hematology and oncology education. The presentations will reflect on the impact of last year’s programs, including a virtual patient simulation and collaborations with the Leukemia & Lymphoma Society. Additionally, Medscape will introduce new AI capabilities to enhance learning experiences for healthcare professionals, reinforcing their commitment to improving patient care through innovative education.
As the conference year draws to a close, Medscape is closing out the season in a big way, bringing 8 educational symposia and 3 posters to ASH 2024, as well as showcasing new AI capabilities.
Three posters are being presented on December 5, before the official start of the conference. In the first poster, Medscape is taking a retrospective look examining the impact of the programs produced for ASH 2023. The outcomes of this study showed how the programs made a difference in learners’ knowledge, competency, and confidence, as assessed by pre-and post-education questions. Attendees who are interested in simulation can check out Medscape’s second poster, which looks at the impact of a Medscape virtual patient simulation on cold agglutinin disease. Medscape’s third poster, on BTK inhibitors for chronic lymphocytic leukemia and mantle cell lymphoma, was created through the collaboration with The Leukemia & Lymphoma Society, a renowned patient advocacy group.
“It’s always so inspiring to look back at some of our education efforts over the past year and see how much of an impact they made. We’re proud to have worked with the Leukemia & Lymphoma Society to analyze and present the impact of some of our education in chronic lymphocytic leukemia and mantle cell lymphoma and show how education is making a difference,” said Dr Victoria Harvey-Jones, Associate Director of Clinical Strategy, Medscape Oncology Global and leader of Medscape’s Patient-Integration Initiative.
The 8 educational symposia for 2024 will cover the following topics:
- Collaborating for Optimal Immune Thrombocytopenia Care: Uniting Disease, Treatment, and Patient-Centered Considerations:
- Maximizing Touchpoints to Empower Impactful Patient-Centered Care for PNH
- Guiding Our Patient’s Path: Managing First Relapse in Diffuse Large B-Cell Lymphoma Outside of CAR-T
- Escape the Amyloid Maze: Unraveling Data and Care Strategies for AL Amyloidosis
- Bispecific Antibodies: A Playbook for Relapsed/Refractory Follicular Lymphoma
- Sharing Best Practices from the ALL/LBL Clinic: Navigating Patient-Centered Care with Asparaginase Therapies
- Clinical Assessment of Gene Therapies for Hemophilia A and Hemophilia B: Key Takeaways for Your Practice
- Complex Cases in the Community Clinic: Managing Diverse Hematologic Malignancies
All symposia offer the ability to engage with the faculty as well as send notes and slides. Programs will be made available on Medscape.org following the conference.
New for 2024, Medscape will showcase AI features at their booth, allowing attendees to take a glimpse into the powerful ways Medscape is harnessing this technology to enhance education. Conference attendees are encouraged to stop by the Medscape booth during exhibitor hours to try it for themselves.
“Our AI pilot at ASH 2024 is game-changing. We’ve partnered with Erudio Health to pilot new tools that give healthcare professionals new ways to dive into content with AI chatbots and explore real-world cases. It’s not just about better learning – it’s about smarter, faster learning. We’re committed to staying ahead in medical education. Nobody understands medical education like Medscape, and we’re not just keeping up with tech – we’re leading the charge. We’re using our expertise to make AI work for our learners. This AI pilot is just the start. We’re focused on giving healthcare professionals the best learning experience out there, because better education means better patient care.” Dr Sushant Dahiya, Executive Director, Medscape Education
For more information on hematology and oncology education at Medscape, please contact Christine Carey. For more information on patient-integration, please contact Victoria Harvey-Jones, or for how we are harnessing AI to power learning with impact contact Dr Sushant Dahiya.
This content was provided by Medscape Education
Company Details
Latest Content from Medscape Education
The Heart and Mouth Connection Every Woman Needs to Know
For decades, modern medicine has treated the mouth and the body as separate entities. But for Dr. Nieca Goldberg, a renowned cardiologist, and Dr. Maria Ryan, Chief Clinical Officer at...
Uncovering Inequities in Alzheimer’s Disease Screening and Care
On December 5, MAPS hosted an educational webinar exploring recent research in Alzheimer’s disease (AD) screening, testing, and treatment. Experts from Komodo Health and Medscape shared findings from their...
Where Are We Today With Artificial Intelligence (AI) in Rare Disease Diagnosis and Care?
Discover how AI-powered tools are transforming rare disease diagnosis, patient care, and clinical decision-making.
Does Rare Disease Education Work?
For a child with a rare disease, a doctor’s continuing education can end a years-long diagnostic odyssey and unlock access to vital care.
From Genetic Puzzles to Precision Therapeutics
How was a new rare disease discovered through Singapore’s Undiagnosed Disease Program? And how will technology allow us to change how we discover rare diseases in the future? Read more...
Medscape and the GNNRD: Empowering Nurses With a Rare Disease Education Series
Nurses play a vital and multifaceted role in rare disease care, providing consistent patient support, education, and care coordination, and ongoing education is essential to empower them to meet the...
What Is the RDI-Lancet Commission for Rare Disease and What Will It Achieve?
Christy Rohani-Montez, Medscape’s Rare Disease Education Lead recently spoke with Dr Lucy McKay, CEO, and Megan Pullein, Strategic Operations Officer from the UK-based charity Medics for Rare Disease (MfRD). We...
“CGM Sweet Talk With the Sugar Queens” Takes Silver at the 2025 Digital Health Awards
Medscape Education’s dynamic educational series, CGM Sweet Talk With the Sugar Queens, has earned a Silver Award in the Video Series (Digital Health Media / Publications) category at the 2025...
Medscape at ASH 2025: Landmark Value Through the Medscape AI Debut and Five Educational Symposia
For decades, Medscape has been the brand physicians trust. Now, Medscape is forging a new path into the future at ASH 2025 with the launch of Medscape AI — the...
Women Leaders Rewriting the Protocols of Rare Disease Care
The true measure of a medical leader is the courage to act when existing systems fail the patient. This is the professional and personal ethos of clinical immunologist Dr. Hilary...